Vaginal-Stimulating Product Use and Cervicovaginal Health Among Adolescent Girls and Young Women in Rural South Africa: A Cross-Sectional Baseline Study

This cross-sectional baseline study of sexually active HIV-negative adolescent girls and young women in rural South Africa reveals that while vaginal-stimulating product use is highly prevalent, it is significantly associated with cervical ectopy in adults and shows exploratory links to specific STIs and HPV-16 in adolescents, underscoring the need for further longitudinal research to clarify biological risks and inform culturally responsive health interventions.

The Gist

The Big Picture: A Garden in a Busy Neighborhood

Imagine the vagina and cervix (the entrance to the womb) as a delicate garden. This garden is supposed to have a specific balance of soil, moisture, and plants to stay healthy and keep out unwanted weeds (like infections).

In many parts of rural South Africa, there is a common practice where women and girls use special "garden treatments" called Vagina-Stimulating Products (VSPs). People use these for reasons like making the area feel tighter, smelling better, or pleasing a partner. Think of these products like mystery sprays, powders, or potions sold in local markets. No one really knows exactly what is in them, and they aren't regulated like medicine.

This study asked a simple question: Does using these mystery potions help the garden, or does it accidentally damage the soil and let the weeds in?

The Study: A Snapshot in Time

The researchers looked at 252 women in rural South Africa. They split them into two groups:

1. Teenagers (14–19 years old): The "young saplings."
2. Adults (25–35 years old): The "mature trees."

They checked who was using these products, took pictures of their cervixes (like taking a photo of the garden with a special camera), and tested them for infections like HIV, HPV (the virus that causes cervical cancer), and others.

Important Note: This was a "snapshot" study. It's like taking a photo of the garden on one specific day. It can tell us what is happening right now, but it can't prove that the spray caused the damage (maybe the garden was already damaged before the spray was used).

What They Found: The "Garden" Differences

The study found that using these products is very common. About 7 out of 10 women in the study used them. However, the type of product depended on age:

• Teenagers mostly used things they put inside the garden (like powders, crystals, or alum).
• Adults were more likely to use things they swallowed (like pills or herbs) or specific greasy jellies.

1. The Teenagers (The Young Saplings)

• The Good News: Using these products didn't seem to cause immediate, visible damage to the garden walls in the teenagers.
• The Mystery: However, the researchers noticed something interesting. Teenagers who used these products were more likely to have Trichomonas (a common parasite) and HPV-16 (a dangerous virus strain) in their system.
• The Alum Surprise: One specific product, alum (a type of astringent crystal), was actually linked to less visible injury. It's like using a strong astringent that makes the skin look tight and clean, but the researchers warned this might just be a temporary visual trick, not actual healing.

2. The Adults (The Mature Trees)

• The Big Finding: For adult women, using these products (whether inside or swallowed) was strongly linked to Cervical Ectopy.
• What is Ectopy? Imagine the garden has a smooth, tough outer fence (the ectocervix) and a soft, red inner fence (the endocervix). "Ectopy" is when the soft, red inner fence grows out onto the outer fence. It's usually harmless, but it makes the garden look "raw" and more sensitive.
• The Analogy: It's like the soft, tender skin of your inner lip growing onto the hard skin of your cheek. It's not an injury, but it's more sensitive to friction and infection. The study found that women using these products were 3 to 4 times more likely to have this "soft skin" on the outside.

The "Weeds" (Infections)

The study also looked at whether these products let in more "weeds" (infections).

• Teenagers: There was a hint that the products might make it easier for certain viruses (HPV) and parasites to take root, but the numbers were small, so it's not a definite "yes" yet.
• Adults: The link to specific infections wasn't as clear, but the link to the "sensitive skin" (ectopy) was strong.

Why Does This Matter?

Think of the cervix as a security gate for the body.

• If the gate is smooth and tough, it keeps bad guys out.
• If the gate is "raw" (ectopy) or irritated, it's easier for viruses and bacteria to sneak in.

The study suggests that these popular, unregulated "garden treatments" might be changing the texture of the security gate, making it more vulnerable, especially for adult women.

The Takeaway

1. It's Everywhere: Almost everyone is using these products, but they are mostly sold in unregulated markets with unknown ingredients.
2. Age Matters: Teenagers and adults use different types of products and react differently.
3. The Warning: While we can't say for sure that the products caused the infections in this snapshot, the link between using them and having a more "sensitive" cervix (ectopy) is a red flag.
4. Next Steps: The researchers say we need to watch these women over time (like watching a garden grow over a season) to see if using these products actually leads to more infections or cervical cancer later on.

In short: These "mystery potions" are popular, but they might be messing with the delicate balance of the body's natural defenses, potentially opening the door to infections. The study is a call to pay closer attention to what women are putting inside their bodies and to create safer, regulated options.

Technical Summary

1. Problem Statement

Sexually transmitted infections (STIs), including HIV and Human Papillomavirus (HPV), remain a disproportionate burden on Adolescent Girls and Young Women (AGYW) in Sub-Saharan Africa (SSA). While behavioral interventions exist, the biological impact of specific cultural and social practices remains under-characterized. Specifically, the use of Vagina-Stimulating Products (VSPs)—informally produced substances used for sexual enhancement, hygiene, or cultural reasons (e.g., vaginal tightening)—is widespread but poorly understood regarding its effects on mucosal integrity and infection susceptibility. Existing literature lacks integration of colposcopic examination and molecular diagnostics to link these practices to cervicovaginal abnormalities and STI acquisition.

2. Methodology

• Study Design: A cross-sectional baseline analysis of a prospective cohort (Mucosal Injury from Sexual Contact - MISC study).
• Setting: Rural KwaZulu-Natal, South Africa (CAPRISA Vulindlela site), a high HIV/STI burden area.
• Population: 252 HIV-negative, sexually active women stratified by age:
  • Adolescents: 188 participants (14–19 years).
  • Adults: 64 participants (25–35 years).
• Data Collection:
  • Behavioral: Structured questionnaires on VSP use (categorized as intravaginal, ingested, or none), sexual history, and contraceptive use.
  • Clinical: Colposcopic examination using an EVA System to assess mucosal trauma (petechiae, lacerations), inflammation, cervical ectopy, leukoplakia, and genital warts.
  • Laboratory:
    • STI Testing: Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) via urine PCR; Trichomonas vaginalis (TV) via OSOM rapid test and microscopy; Bacterial Vaginosis (BV) via Nugent scoring; Candida via KOH microscopy.
    • HPV Genotyping: Endocervical swabs analyzed using the HPV Direct Flow Chip Kit to detect high-risk (HR) and low-risk (LR) genotypes.
    • Vaginal pH: Measured via test strips.
• Statistical Analysis:
  • Stratified by age group.
  • Multivariable logistic regression adjusted for confounders: age, hormonal contraceptive use, condom use, vaginal pH, and lifetime number of sexual partners.
  • Significance threshold: $p < 0.05$.

3. Key Contributions

• Multimodal Integration: This is one of the few studies to combine self-reported behavioral data with objective colposcopic imaging, molecular HPV genotyping, and STI diagnostics in a single cohort.
• Age-Stratified Insights: The study distinguishes between adolescents and adults, recognizing that cervical physiology (e.g., ectopy prevalence) and product usage patterns differ significantly by developmental stage.
• Product Specificity: Instead of grouping all "vaginal products" together, the study analyzes specific substances (e.g., Alum, Ibhodwe labafazi, snuff) and routes of administration (intravaginal vs. ingested).
• Contextualization: It situates VSP use within the socio-relational context of rural South Africa, linking product use to gender norms and partner negotiation.

4. Key Results

Prevalence and Patterns of Use

• High Prevalence: VSP use was common in both groups (68.1% of adolescents; 69.8% of adults).
• Route Differences: Adolescents favored intravaginal use (41.5%), while adults favored ingested products (44.4%).
• Specific Products:
  • Adolescents: High use of Alum (33.3%).
  • Adults: High use of Ibhodwe labafazi (a petroleum jelly-based product) (56.3%).

Cervicovaginal Abnormalities

• Adolescents: No statistically significant association was found between general VSP use and cervical ectopy, leukoplakia, or visible injury after adjustment.
  • Notable Finding: Alum use was associated with lower odds of visible cervicovaginal injury/inflammation (aOR 0.14; 95% CI 0.04–0.48), though the authors caution this may reflect astringent effects on colposcopic appearance rather than true mucosal protection.
• Adults: Both intravaginal (aOR 3.7; 95% CI 1.2–11.8) and ingested (aOR 2.9; 95% CI 1.1–8.5) VSP use were significantly associated with cervical ectopy.
  • Note: While ectopy is typically physiological in adolescents, its persistence or higher prevalence in adult VSP users suggests a potential product-induced alteration in epithelial characteristics.

Infection and HPV Associations

• STIs: Among adolescents, VSP users had a significantly higher prevalence of Trichomonas vaginalis ($p=0.021$).
• HPV:
  • Adolescents: VSP users showed higher prevalence of HPV-16 ($p=0.007$) and overall high-risk HPV.
  • Adults: Vaginal product users had higher prevalence of Low-Risk HPV types (62/81, 6), while ingested product users showed higher prevalence of HPV-35.

5. Significance and Limitations

• Significance:
  • The findings suggest that VSP use is a modifiable behavioral risk factor that may intersect with mucosal health and infection risk, particularly cervical ectopy in adults and STI/HPV acquisition in adolescents.
  • The study highlights the need for culturally responsive sexual health interventions and regulatory attention to the informal market of vaginal products.
  • It provides a hypothesis-generating framework for longitudinal studies to establish causality.
• Limitations:
  • Cross-Sectional Design: Cannot establish temporality (i.e., whether VSP use caused the abnormalities or vice versa).
  • Self-Reporting: Potential for recall or social desirability bias; chemical composition of products was largely unknown.
  • Sample Size: Limited power for product-specific and genotype-specific analyses, particularly in the adult subgroup, leading to wide confidence intervals.
  • Abstinence Requirement: The 2-week abstinence rule prior to enrollment may have attenuated the detection of acute mucosal trauma.

Conclusion

VSP use is highly prevalent among AGYW in rural South Africa with distinct age-specific patterns. While causality is not established, the study identifies statistically significant associations between VSP use and cervical ectopy in adults, and exploratory links to Trichomonas and HPV-16 in adolescents. These findings underscore the necessity for longitudinal mechanistic studies to clarify the biological pathways linking intravaginal practices to infection risk and cervical health.